261 related articles for article (PubMed ID: 31692250)
1. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
Zamora LD; Collante MTM; Navarra SV
Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
3. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
Borba EF; Ribeiro AC; Martin P; Costa LP; Guedes LK; Bonfá E
J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
Chakravarty EF; Michaud K; Katz R; Wolfe F
Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster in systemic lupus erythematosus.
Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Mok CC; Ho LY; Tse SM; Chan KL; To CH
Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
[TBL] [Abstract][Full Text] [Related]
9. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
[TBL] [Abstract][Full Text] [Related]
11. Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in Chinese children with systemic lupus erythematosus.
Wu SA; Yeh KW; Yao TC; Huang JL
Pediatr Infect Dis J; 2011 Aug; 30(8):656-60. PubMed ID: 21343839
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2020 Jul; 29(8):836-844. PubMed ID: 32408851
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years.
Reggiani F; Cardi S; Tumminello F; Calatroni M; Locatelli L; Gerosa M; Del Papa N; Moroni G
Front Immunol; 2023; 14():1293269. PubMed ID: 38077357
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Akawatcharangura P; Taechakraichana N; Osiri M
Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system infections in Filipino patients with systemic lupus erythematosus.
Vargas PJ; King G; Navarra SV
Int J Rheum Dis; 2009 Sep; 12(3):234-8. PubMed ID: 20374352
[TBL] [Abstract][Full Text] [Related]
17. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders.
Pope JE; Krizova A; Ouimet JM; Goodwin JL; Lankin M
J Rheumatol; 2004 Feb; 31(2):274-9. PubMed ID: 14760796
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
Kahl LE
J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
[TBL] [Abstract][Full Text] [Related]
20. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
Steiger S; Ehreiser L; Anders J; Anders HJ
Front Immunol; 2022; 13():999704. PubMed ID: 36211360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
